Drug Type Antibody drug conjugate (ADC) |
Synonyms- |
Target |
Mechanism PDL1 inhibitors(Programmed death-ligand 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC27H29NO11 |
InChIKeyAOJJSUZBOXZQNB-TZSSRYMLSA-N |
CAS Registry23214-92-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Colorectal Cancer | Preclinical | - | - |